Cited by 122Stress Responses and CortisolEstrogen and related hormone effectsAdrenal Hormones and Disorders

Differential targeting of brain stress circuits with a selective glucocorticoid receptor modulator

Open access
Zalachoras, Ioannis, Houtman, René, Atucha, Erika, Devos, Rene, Tijssen, Ans M. I., Hu, Pu, Lockey, Peter M., Datson, Nicole A. +7 more·2013·Proceedings of the National Academy of Sciences

Abstract

Glucocorticoid receptor (GR) antagonism may be of considerable therapeutic value in stress-related psychopathology such as depression. However, blockade of all GR-dependent processes in the brain will lead to unnecessary and even counteractive effects, such as elevated endogenous cortisol levels. Selective GR modulators are ligands that can act both as agonist and as antagonist and may be used to separate beneficial from harmful treatment effects. We have discovered that the high-affinity GR ligand C108297 is a selective modulator in the rat brain. We first demonstrate that C108297 induces a unique interaction profile between GR and its downstream effector molecules, the nuclear receptor coregulators, compared with the full agonist dexamethasone and the antagonist RU486 (mifepristone). C108297 displays partial agonistic activity for the suppression of hypothalamic corticotropin-releasing hormone (CRH) gene expression and potently enhances GR-dependent memory consolidation of training on an inhibitory avoidance task. In contrast, it lacks agonistic effects on the expression of CRH in the central amygdala and antagonizes GR-mediated reduction in hippocampal neurogenesis after chronic corticosterone exposure. Importantly, the compound does not lead to disinhibition of the hypothalamus–pituitary–adrenal axis. Thus, C108297 represents a class of ligands that has the potential to more selectively abrogate pathogenic GR-dependent processes in the brain, while retaining beneficial aspects of GR signaling.

Integrity signals

Registry

Crossref · 10.1073/pnas.1219411110

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zalachoras, I., Houtman, R., Atucha, E., Devos, R., Tijssen, A. M. I., Hu, P., Lockey, P. M., Datson, N. A., Belanoff, J. K., Lucassen, P. J., Joëls, M., de Kloet, E. R., Roozendaal, B., Hunt, H., & Meijer, O. C.
Affiliations
  • Leiden University Medical Center (NL)
  • PamGene (Netherlands) (NL)
  • Radboud University Nijmegen (NL)
  • Argenta Discovery, Harlow, Essex CM19 5TR, United Kingdom;
  • Division Medical Pharmacology, Leiden/Amsterdam Center for Drug Research, 2300 RA Leiden, The Netherlands;
  • University of Amsterdam (NL)
  • Corcept Therapeutics (United States) (US)
  • University Medical Center Utrecht (NL)
Venue
Proceedings of the National Academy of Sciences
Published
2013-04-23
Volume
110
Issue
19
Pages
7910-7915
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2161618887
Cited by
121
References
50
Citations by year
2026: 4 · 2025: 1 · 2024: 6 · 2023: 11 · 2022: 9 · 2021: 6 · 2020: 4 · 2019: 15 · 2018: 15 · 2017: 10 · 2016: 16 · 2015: 8 · 2014: 9 · 2013: 7
FWCI
6.05
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • UvA-DARE (University of Amsterdam) (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Leiden Repository (Leiden University) (submittedVersion)
  • UvA-DARE (University of Amsterdam) (submittedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
Topics
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
glucocorticoid receptor, selective glucocorticoid receptor modulators, depression, corticotropin-releasing factor, hypothalamus, central amygdala, hippocampal neurogenesis, hypothalamic-pituitary-adrenal axis, nuclear receptor coregulators, dexamethasone, mifepristone, chronic corticosterone
MeSH terms
Animals, Brain, Corticotropin-Releasing Hormone, Dexamethasone, Gene Expression Regulation, Hippocampus, Ligands, Male, Peptides, Receptors, Glucocorticoid, Steroids, Time Factors, Transcription, Genetic, Mifepristone, Rats, Sprague-Dawley, Two-Hybrid System Techniques, Rats, Nuclear Receptor Coactivator 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review